
Loading, please wait...

Loading, please wait...

Recurrent CT imaging risks are a significant concern in modern clinical practice. While computed tomography remains an indispensable diagnostic tool, its contribution to medical radiation exposure is substantial. Most patients undergo only a few scans during their lifetime. However, a specific subset of patients frequently requires repeat imaging, leading to high cumulative effective doses (CEDs). Consequently, clinicians must balance the immediate diagnostic benefits against the long-term stochastic risks of radiation.
To address these challenges, researchers have proposed the Recurrent Exposure Reference Level (RERL). This benchmark serves as a tool for monitoring cumulative doses in patients who undergo frequent imaging. A recent study conducted at Vilnius University Hospital Santaros Klinikos analyzed over 99,000 CT examinations to establish a local RERL. The study found that while the annual incidence of high-dose patients remained stable, nearly 18% of recurrent patients exceeded a CED of 100 mSv within three years. Interestingly, most of these patients reached this threshold with fewer than five CT examinations.
Managing recurrent CT imaging risks requires a multi-faceted approach involving both radiologists and referring physicians. The study established a local RERL of 36 mSv, which aligns with international European benchmarks. This value provides a practical trigger for dose optimization and clinical justification. Furthermore, systematic dose tracking software can alert clinicians when a patient is approaching high-dose thresholds. Therefore, integrating RERLs into routine hospital workflows ensures that every scan is strictly justified and optimized for safety.
Clinicians should prioritize the principles of justification and optimization (ALARA). In India, where CT usage is increasing, implementing cumulative dose monitoring is essential. If a patient requires frequent imaging, clinicians should consider alternative modalities like MRI or ultrasound when appropriate. Additionally, using low-dose protocols and AI-enhanced reconstruction can further reduce the individual scan dose without compromising diagnostic quality.
An RERL is a benchmark used to monitor the cumulative radiation dose of patients who undergo multiple CT scans. It helps identify patients at risk of high radiation exposure and triggers a review of imaging necessity.
A cumulative effective dose (CED) of 100 mSv is often cited as a level where the long-term risks of radiation-induced stochastic effects, such as cancer, become a more prominent clinical concern.
Hospitals can utilize automated radiation dose management systems that integrate with PACS and electronic health records to track and flag high cumulative doses in real-time.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional clinical judgment. Refer to the latest local and national guidelines for clinical practice.
References
Jreije A et al. Recurrent CT imaging and strategies for patient radiation protection. J Radiol Prot. 2026 Feb 12. doi: 10.1088/1361-6498/ae4521. PMID: 41678845.
Rehani MM, et al. Global prevalence of patients with high cumulative doses from medical imaging. Eur J Radiol. 2020;126:108928.
International Atomic Energy Agency (IAEA). Radiation Protection and Safety in Medical Uses of Ionizing Radiation. Safety Standards Series No. SSG-46. 2018.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study highlights the importance of monitoring cumulative radiation doses and using Recurrent Exposure Reference Levels (RERL) to mitigate CT-related risks...
8 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today